Eli Lilly (LLY) stock climbs 2% after Citigroup sets $1,600 price target and Berenberg upgrades to Buy on obesity drug strength and pipeline growth. The post Eli Lilly (LLY) Stock Surges on Dual Analyst Upgrades and $1,600 Price Target appeared first on Blockonomi.